Bildkälla: Stockfoto

Pila Pharma: Rights Issue Outcome - Redeye

Redeye leaves a short comment on Pila Pharma following the outcome of its rights issue which raised SEK6.9m before issuing costs.

Redeye leaves a short comment on Pila Pharma following the outcome of its rights issue which raised SEK6.9m before issuing costs.
Börsvärldens nyhetsbrev
ANNONSER